116 related articles for article (PubMed ID: 38060262)
1. Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants.
Villy MC; Le Ven A; Le Mentec M; Masliah-Planchon J; Houy A; Bièche I; Vacher S; Vincent-Salomon A; Dubois d'Enghien C; Schwartz M; Piperno-Neumann S; Matet A; Malaise D; Bubien V; Lortholary A; Ait Omar A; Cavaillé M; Stoppa-Lyonnet D; Cassoux N; Stern MH; Rodrigues M; Golmard L; Colas C
J Natl Cancer Inst; 2024 Apr; 116(4):580-587. PubMed ID: 38060262
[TBL] [Abstract][Full Text] [Related]
2. Germline loss-of-function variants in MBD4 are rare in Finnish patients with uveal melanoma.
Repo P; Jäntti JE; Järvinen RS; Rantala ES; Täll M; Raivio V; Kivelä TT; Turunen JA
Pigment Cell Melanoma Res; 2020 Sep; 33(5):756-762. PubMed ID: 32421892
[TBL] [Abstract][Full Text] [Related]
3. Germline MBD4 Mutations and Predisposition to Uveal Melanoma.
Derrien AC; Rodrigues M; Eeckhoutte A; Dayot S; Houy A; Mobuchon L; Gardrat S; Lequin D; Ballet S; Pierron G; Alsafadi S; Mariani O; El-Marjou A; Matet A; Colas C; Cassoux N; Stern MH
J Natl Cancer Inst; 2021 Jan; 113(1):80-87. PubMed ID: 32239153
[TBL] [Abstract][Full Text] [Related]
4. Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab.
Johansson PA; Stark A; Palmer JM; Bigby K; Brooks K; Rolfe O; Pritchard AL; Whitehead K; Warrier S; Glasson W; Hayward NK
Immunogenetics; 2019 May; 71(5-6):433-436. PubMed ID: 30714079
[TBL] [Abstract][Full Text] [Related]
5. MBD4-associated neoplasia syndrome: screening of cases with suggestive phenotypes.
Terradas M; Gonzalez-Abuin N; García-Mulero S; Viana-Errasti J; Aiza G; Piulats JM; Brunet J; Capellá G; Valle L
Eur J Hum Genet; 2023 Oct; 31(10):1185-1189. PubMed ID: 37402954
[TBL] [Abstract][Full Text] [Related]
6. Germline MBD4 deficiency causes a multi-tumor predisposition syndrome.
Palles C; West HD; Chew E; Galavotti S; Flensburg C; Grolleman JE; Jansen EAM; Curley H; Chegwidden L; Arbe-Barnes EH; Lander N; Truscott R; Pagan J; Bajel A; Sherwood K; Martin L; Thomas H; Georgiou D; Fostira F; Goldberg Y; Adams DJ; van der Biezen SAM; Christie M; Clendenning M; Thomas LE; Deltas C; Dimovski AJ; Dymerska D; Lubinski J; Mahmood K; van der Post RS; Sanders M; Weitz J; Taylor JC; Turnbull C; Vreede L; van Wezel T; Whalley C; Arnedo-Pac C; Caravagna G; Cross W; Chubb D; Frangou A; Gruber AJ; Kinnersley B; Noyvert B; Church D; Graham T; Houlston R; Lopez-Bigas N; Sottoriva A; Wedge D; ; ; ; Jenkins MA; Kuiper RP; Roberts AW; Cheadle JP; Ligtenberg MJL; Hoogerbrugge N; Koelzer VH; Rivas AD; Winship IM; Ponte CR; Buchanan DD; Power DG; Green A; Tomlinson IPM; Sampson JR; Majewski IJ; de Voer RM
Am J Hum Genet; 2022 May; 109(5):953-960. PubMed ID: 35460607
[TBL] [Abstract][Full Text] [Related]
7. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
[TBL] [Abstract][Full Text] [Related]
8. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma.
Abdel-Rahman MH; Pilarski R; Ezzat S; Sexton J; Davidorf FH
Fam Cancer; 2010 Sep; 9(3):431-8. PubMed ID: 20157784
[TBL] [Abstract][Full Text] [Related]
9. High risk of breast cancer in women with biallelic pathogenic variants in CHEK2.
Rainville I; Hatcher S; Rosenthal E; Larson K; Bernhisel R; Meek S; Gorringe H; Mundt E; Manley S
Breast Cancer Res Treat; 2020 Apr; 180(2):503-509. PubMed ID: 31993860
[TBL] [Abstract][Full Text] [Related]
10. BAP1 germline mutation in two first grade family members with uveal melanoma.
Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
[TBL] [Abstract][Full Text] [Related]
11. Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis.
Barreiro RAS; Sabbaga J; Rossi BM; Achatz MIW; Bettoni F; Camargo AA; Asprino PF; A F Galante P
J Pathol; 2022 Feb; 256(2):214-222. PubMed ID: 34816434
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Characterization of Biallelic and Monoallelic
Salo-Mullen EE; Maio A; Mukherjee S; Bandlamudi C; Shia J; Kemel Y; Cadoo KA; Liu Y; Carlo M; Ranganathan M; Kane S; Srinivasan P; Chavan SS; Donoghue MTA; Bourque C; Sheehan M; Tejada PR; Patel Z; Arnold AG; Kennedy JA; Amoroso K; Breen K; Catchings A; Sacca R; Marcell V; Markowitz AJ; Latham A; Walsh M; Misyura M; Ceyhan-Birsoy O; Solit DB; Berger MF; Robson ME; Taylor BS; Offit K; Mandelker D; Stadler ZK
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250384
[TBL] [Abstract][Full Text] [Related]
13. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
16.
Villy MC; Masliah-Planchon J; Schnitzler A; Delhomelle H; Buecher B; Filser M; Merchadou K; Golmard L; Melaabi S; Vacher S; Blanluet M; Suybeng V; Corsini C; Dhooge M; Hamzaoui N; Farelly S; Ait Omar A; Benamouzig R; Caumette V; Bahuau M; Cucherousset J; Allory Y; Stoppa-Lyonnet D; Bieche I; Colas C
J Med Genet; 2023 Nov; 60(12):1198-1205. PubMed ID: 37402566
[TBL] [Abstract][Full Text] [Related]
17. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
20. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]